Results 111 to 120 of about 11,714 (178)

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis [PDF]

, 2013
Zoledronic acid, a bisphosphonate, has been approved for treatment and prevention of osteoporosis. This case describes a 73-year-old woman with primary osteoporosis who developed transient hepatotoxicity after zoledronic acid (ZOL) treatment.
Fang, Fusheng, Jin, Mengmeng, Li, Chunlin, Li, Jian, Liu, Minyan, Lu, Yanhui, Ma, Lichao, Pei, Yu, Shao, Yinghong, Yan, Shuangtong   +9 more
core  

Update on the pathogenesis and genetics of Paget's disease of bone. [PDF]

Front Cell Dev Biol, 2022
Gennari L, Rendina D, Merlotti D, Cavati G, Mingiano C, Cosso R, Materozzi M, Pirrotta F, Abate V, Calabrese M, Falchetti A.   +10 more
europepmc   +1 more source

Optineurin regulates osteoblast function in an age-dependent fashion in a mouse model of Paget's disease of bone. [PDF]

Bone, 2023
Hu X, Foster BL, Zhao B, Tseng HC, Wu YC, Ko CC.   +5 more
europepmc   +1 more source

Genetic Determinants of Paget's Disease of Bone. [PDF]

Curr Osteoporos Rep, 2021
Makaram NS, Ralston SH.
europepmc   +1 more source

Newly Diagnosed Monostotic Paget's Disease of Bone during Living Kidney Donor Candidate Evaluation. [PDF]

Biomedicines, 2023
Jędrzejuk D, Poznański P, Szewczyk P, Mazanowska O, Bolanowski M, Krajewska M, Kamińska D.   +6 more
europepmc   +1 more source

Paget's disease of bone: Report of 11 cases. [PDF]

World J Clin Cases, 2021
Miao XY, Wang XL, Lyu ZH, Ba JM, Pei Y, Dou JT, Gu WJ, Du J, Guo QH, Chen K, Mu YM.   +10 more
europepmc   +1 more source

Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget's disease of bone. [PDF]

Sci Adv, 2023
Hu X, Wong SW, Liang K, Wu TH, Wang S, Wang L, Liu J, Yamauchi M, Foster BL, Ting JP, Zhao B, Tseng HC, Ko CC.   +12 more
europepmc   +1 more source

Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget's Disease of Bone with PFN1 Mutation Are Treatable by Alendronate. [PDF]

Pharmaceuticals (Basel), 2023
Ling Z, Aini H, Kajikawa S, Shirakawa J, Tsuji K, Asou Y, Koga H, Sekiya I, Nifuji A, Noda M, Ezura Y.   +10 more
europepmc   +1 more source

Clinical Characteristics and Pathogenic Gene Identification in Chinese Patients With Paget's Disease of Bone. [PDF]

Front Endocrinol (Lausanne), 2022
Tao X, Liu L, Yang X, Wei Z, Chen Z, Zhang G, Zhang Z, Yue H.   +7 more
europepmc   +1 more source

Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget's Disease of Bone. [PDF]

Int J Mol Sci, 2021
Paoletta M, Moretti A, Liguori S, Di Paola A, Tortora C, Argenziano M, Rossi F, Iolascon G.   +7 more
europepmc   +1 more source